Bart Post was born on March 30, 1972 in Grootebroek, the Netherlands. He obtained his medical degree in 1999 at the University of Maastricht (with honors). In 2000 he started his training as a resident in Neurology at the Academic Medical Centre in Amsterdam (head: prof. dr. M. Vermeulen), which he completed in December 2008. In 2002 he started a research project on ‘Prognosis in Parkinson’s disease’ that resulted in a PhD thesis in 2009. In 2006 he started a master of Sciences (MSc) education in clinical epidemiology at the EMGO institute in Amsterdam. In 2009 he was certified as a clinical epidemiologist. Since 2010 he works as a movement disorder neurologist in the Parkinson Centre in the Radboudumc in Nijmegen (head: prof. dr. B. Bloem). He is part of the steering committee of two large Parkinson trials in the Netherlands: the LEAP-trial (Early administration of levodopa in de novo PD); and the CHEVAL-trial (administration of acetylcholine inhibitors in PD patients with hallucinations). Furthermore he was an expert-rater at the EARLY-STIM trial (German-French trial on DBS early in the course of PD). At the department of neurology of the Radboudumc he is chair of the residency program for neurologists.


Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone

Latest News Articles

Contact Us


Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon
Senior Project Manager (IT): Delphine Smagghe
Project Manager (IT): Stephanie Le Naour


Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France


Paris Inserm Transfert

Go to top